- Home
- INSG vs NKTR Comparison
INSG vs NKTR Comparison
Compare INSG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- NKTR
- Stock Information
- Founded
- INSG 1996
- NKTR 1990
- Country
- INSG United States
- NKTR United States
- Employees
- INSG N/A
- NKTR N/A
- Industry
- INSG Telecommunications Equipment
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- NKTR Health Care
- Exchange
- INSG Nasdaq
- NKTR Nasdaq
- Market Cap
- INSG 110.6M
- NKTR 108.3M
- IPO Year
- INSG 2000
- NKTR 1994
- Fundamental
- Price
- INSG $7.67
- NKTR $24.07
- Analyst Decision
- INSG Buy
- NKTR Strong Buy
- Analyst Count
- INSG 3
- NKTR 6
- Target Price
- INSG $13.00
- NKTR $81.67
- AVG Volume (30 Days)
- INSG 226.7K
- NKTR 4.8M
- Earning Date
- INSG 08-06-2025
- NKTR 08-07-2025
- Dividend Yield
- INSG N/A
- NKTR N/A
- EPS Growth
- INSG N/A
- NKTR N/A
- EPS
- INSG 0.31
- NKTR N/A
- Revenue
- INSG $185,412,000.00
- NKTR $87,248,000.00
- Revenue This Year
- INSG N/A
- NKTR N/A
- Revenue Next Year
- INSG $14.39
- NKTR N/A
- P/E Ratio
- INSG $24.70
- NKTR N/A
- Revenue Growth
- INSG 20.40
- NKTR N/A
- 52 Week Low
- INSG $6.24
- NKTR $6.48
- 52 Week High
- INSG $20.67
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- INSG 43.20
- NKTR 64.55
- Support Level
- INSG $8.06
- NKTR $21.87
- Resistance Level
- INSG $9.07
- NKTR $26.29
- Average True Range (ATR)
- INSG 0.44
- NKTR 4.06
- MACD
- INSG -0.06
- NKTR -0.06
- Stochastic Oscillator
- INSG 3.45
- NKTR 38.83
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.